Bausch+Lomb Results Presentation Deck
R&D Delivering Opportunities in High Growth, High Margin Categories ¹
Expected to Launch More than 15 Products in 2023
2023
Launches
BAUSCH + LOMB
Vision Care/
Consumer
Growing market
share with new
products, line extensions
and geo-expansion
Ophthalmic Pharmaceuticals
Launching high-margin
pharmaceutical products
Surgical
Shift surgical portfolio
to premium categories
M&A
Supported by
M & A
1. See Slide 1 for further information on forward-looking statements.
2. Launched in 2022 with continued growth in 2023 and beyond.
BAUSCH&LOME
LUMIFY
PREMIUM S
www.m
Le
Lumify®
geo-expansion
PreserVision
en Vista®
Premium.
IOL Expansion
AREDS 2
LUME
20 2
Enhanced PreserVision®
AREDS 2 Formula Mini
Soft Gels with OCUSorb™
XIPERE™
2
Teneo™M Excimer
Laser for Refractive
Surgery (US)
he
PreserVision
AREDS 2
CoQ10
100, 2
LUKSMART
SMART
PreserVision®
AREDS2+ CoQ10
MICKILAR EYELID CLEANSGES
LISTA FOR
VYZULTAT
Lux Premium
IOL Expansion
Post IPO, completed 6 acquisitions/licensing
transactions to enhance pipeline
true
e eyeTELLIGENCE
eye Telligence®
digital ecosystem
Bio
true
INFUSE
Daily SiHy Multifocal
Daily SiHy
VYZULTAⓇ
geo-expansion
3D Microscope
AcuFocus
true
geo-expansion
Bio
true
Minimally Invasive
Micro Sclerostomy
("MIMSⓇ")
HIRAPOR
BAUSCH + LOMB
ARISE
ORTHO-K SYSTEM
NOV03
IC-8®
Apthera ™M IOL
Sanoculis
25View entire presentation